Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases

Podobne zapisy

• Analysis of the prevalence of subtypes of angioedema without urticaria in a reference center in Rio de Janeiro – Brazil
  od: Fernandes, Renata Silva, i wsp.
  Wydane: (2015)
• Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis
  od: da Cunha, Fernanda Sales, i wsp.
  Wydane: (2018)
• Impact of chronic urticaria on the quality of life of patients followed up at a university hospital
  od: Dias, Gabriela Andrade Coelho, i wsp.
  Wydane: (2016)
• Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
  od: Che-Wen Yang, i wsp.
  Wydane: (2017-12-01)
• Short-term prophylaxis (STP) with plasma derived human C1 inhibitor concentrate (pdhC1-INH) in two pregnant women with hereditary angioedema (HAE): an experience in Rio de Janeiro – Brazil
  od: Valle, Solange Oliveira Rodrigues, i wsp.
  Wydane: (2015)